Relief Therapeutics Holding AG announced that it has entered into a definitive agreement to issue 1,500,000 shares, warrants and associated warrants for a gross proceeds of CHF 5,000,000 on June 16, 2023. The warrants issued will be used to acquire up to 1,500,000 shares at a purchase price of CHF 3.33 per share. The warrants will have an exercise price of CHF 3.40 per share, will be immediately exercisable upon issuance, and will expire five years from the date of issuance.

The closing of the transaction is expected on June 21, 2023. The private placement shares and, upon exercise, the shares underlying the warrants, will be traded on the SIX Swiss Exchange and rank pari passu (carrying the same rights) with the company's ordinary shares, and will be delivered from the company's treasury shares previously issued out of its authorized share capital under exclusion of the existing shareholders' pre-emptive rights.